Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

News > All

Total search results: 9842 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 17 18 19 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Topas Therapeutics GmbH. (1/25/18). "Press Release: Topas Therapeutics Serves as Exclusive Translational Partner for Collaborative Research Center Focused on Liver Inflammation at University Medical Center Hamburg-Eppendorf". Hamburg. 2018-01-25
Novartis AG. (1/24/18). "Press Release: Novartis Delivered Good Operational Performance and Landmark Innovation in 2017, Entering Our Next Growth Phase". Basel. 2018-01-24
Novartis AG. (1/24/18). "Press Release: Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss". Basel. 2018-01-24
ImmuPharma plc. (1/24/18). "Press Release: Successful Placing to Raise £10 Million". 2018-01-24
Qlucore AB. (1/24/18). "Press Release: Enhanced Collaboration between Qlucore and Nebion to Help Biologists Get More Out of Their Data Analysis". 2018-01-24
CureVac AG. (1/24/18). "Press Release: CureVac Expands Intellectual Property Position that Significantly Improves Protein Expression for its mRNA-Based Vaccines and Therapeutics". Tübingen. 2018-01-24
Genedata AG. (1/24/18). "Press Release: Genedata, HighRes Biosolutions, and Titian Software Collaborate for Automated End-to-End Screening Solution". Basel, Beverly, CA & London. 2018-01-24
Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. 2018-01-24
Qiagen N.V.. (1/23/18). "Press Release: Qiagen Receives FDA Clearance for First-ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms". Hilden & Germantown, MD. 2018-01-23
High-Tech Gründerfonds Management GmbH. (1/23/18). "Press Release: Dräger Invests in HTGF III". 2018-01-23
BCNP Consultants GmbH. (1/22/18). "Press Release: 23rd February Chemistry Industry Innovators from 27 Countries Will Meet at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-01-22
Celgene Corporation. (1/22/18). "Press Release: Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ & Seattle, WA. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Completes Tender Offer for Advanced Accelerator Applications S.A. and Announces Commencement of Subsequent Offering Period". Basel. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Reports Erenumab Met All Primary and Secondary Endpoints in Unique Phase IIIb Study in Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments". Basel. 2018-01-22
Genmab A/S. (1/22/18). "Press Release: Genmab Announces Novartis' Intention to Transition Arzerra (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets". Copenhagen. 2018-01-22
Sanofi S.A.. (1/19/18). "Press Release: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee". Paris. 2018-01-19
Biotest AG. (1/19/18). "Press Release: All Conditions Met for Creat Takeover of Biotest". Dreieich. 2018-01-19
Qiagen N.V.. (1/18/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-01-18
Inositec AG. (1/18/18). "Press Release: Inositec AG Appoints Dr Frits van Alphen as Chief Medical Officer". Zurich. 2018-01-18
ERS Genomics Ltd.. (1/18/18). "Press Release: ERS Genomics Responds to Revocation of Broad Institute European Patent". Dublin. 2018-01-18
Novartis AG. (1/18/18). "Press Release: Sandoz Announces Exclusive Global Collaboration with Biocon on Next-generation Biosimilars". Holzkirchen. 2018-01-18
Selexis S.A.. (1/17/18). "Press Release: Selexis SA Appoints Alberto Garotti as Chief Financial Officer". Geneva. 2018-01-17
Synpromics Ltd.. (1/17/18). "Press Release: Synpromics Appoints Sarah Haecker Meeks, PhD as Vice President of Business Development. Company Establishes U.S. Subsidiary to Expand Operations". Edinburgh. 2018-01-17
Novartis AG. (1/17/18). "Press Release: Novartis Granted US FDA Priority Review for Kymriah (tisagenlecleucel), formerly CTL019, for Adults with r/r DLBCL". Basel. 2018-01-17
Helmholtz-Zentrum München. (1/17/18). "Press Release: Innovative Antibody Production. Helmholtz Association Funding Spin-off". 2018-01-17
Immatics Biotechnologies GmbH. (1/17/18). "Press Release: Immatics Appoints Thomas Ulmer as Chief Financial Officer". Tübingen & Houston, TX. 2018-01-17
Novartis AG. (1/16/18). "Press Release: Novartis New Data Reinforces Superiority of Cosentyx versus Stelara in Achieving Skin Clearance for Psoriasis Patients". Basel. 2018-01-16
Novartis AG. (1/16/18). "Press Release: Sandoz Regulatory Submission for Proposed Biosimilar Adalimumab Accepted by FDA". Holzkirchen. 2018-01-16
Owkin. (1/16/18). "Press Release: Owkin Closes $11 Million Series A Financing Round". New York, NY. 2018-01-16
Merck KGaA. (1/16/18). "Press Release: Merck Presents Data on Bifunctional Immunotherapy M7824 at ASCO 2018 Gastrointestinal Cancers Symposium". Darmstadt. 2018-01-16
BioNTech Diagnostics GmbH. (1/15/18). "Press Release: BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper". Mainz. 2018-01-15
Roche. (1/12/18). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in the European Union for Relapsing Forms of Multiple Sclerosis and Primary Progressive Multiple Sclerosis". Basel. 2018-01-12
Mind the Byte S.L.. (1/11/18). "Press Release: Mind the Byte Acquires Intelligent Pharma". 2018-01-11
Novartis AG. (1/11/18). "Press Release: Novartis Appoints Elizabeth Barrett as Oncology Head". Basel. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer". Menlo Park, CA. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate on a Novel Immuno-Oncology Combination for Leukemia and Bladder Cancer". Menlo Park, CA. 2018-01-11
Immunic AG. (1/11/18). "Press Release: FDA Approves IND for Immunic Therapeutics’ IMU-838 to Proceed with Phase 2 Study in Ulcerative Colitis". Planegg-Martinsried. 2018-01-11
Gilde Healthcare Partners. (1/11/18). "Press Release: Gilde Healthcare Opens Office in Frankfurt Germany". Utrecht & Frankfurt a. M.. 2018-01-11
Genedata AG. (1/11/18). "Press Release: Genedata Announces New Solution for CRISPR Data Management and Analysis". Basel. 2018-01-11
Sophia Genetics S.A.. (1/11/18). "Press Release: Sophia Genetics Appoints Valentin Matillon as New Chief Financial Officer". St. Sulpice. 2018-01-11
Enamine Ltd.. (1/10/18). "Press Release: Enamine Supplies DSI Poised Fragment and Analogue Libraries to Diamond Light Source XChem Facility and SGC Oxford Screening Efforts". Kiev & Oxford. 2018-01-10
Basilea Pharmaceutica Ltd.. (1/10/18). "Press Release: Basilea Announces Completion of the License Agreement Extension with Pfizer for Antifungal Cresemba for China and Asia Pacific". Basel. 2018-01-10
Scancell Holdings plc. (1/9/18). "Press Release: Scancell to Collaborate with BioNTech to Investigate T cell Receptor based Therapeutics for the Treatment of Cancer". 2018-01-09
Novartis AG. (1/9/18). "Press Release: Novartis Advances Head-to-head Superiority Trials of Cosentyx versus Humira and Proposed Biosimilar Adalimumab". Basel. 2018-01-09
Boehringer Ingelheim. (1/9/18). "Press Release: BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab". Cambridge, MA, Beijing & China. 2018-01-09
XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation® Technology". Freising. 2018-01-09
Genedata AG. (1/9/18). "Press Release: Genedata Screener Raises the Bar on Automation in 2018". Basel. 2018-01-09
MLM Medical Labs GmbH. (1/9/18). "Press Release: New S1 Lab Expands MLM’s Service Portfolio". 2018-01-09
Cell Medica Ltd.. (8/1/18). "Press Release: Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation". London & Houston, TX. 2018-01-08
Roche. (1/8/18). "Press Release: Roche and GE Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment". Basel. 2018-01-08
European Invesmtent Bank (EIB). (1/8/18). "Press Release: Investment Plan for Europe. EIB Grants Loan of EUR 40m to Indivumed". 2018-01-08
Evotec AG. (1/8/18). "Press Release: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi". Hamburg & Vienna. 2018-01-08
BioNTech AG. (1/4/18). "Press Release: BioNTech Secures USD 270 Million in Series A Financing". Mainz. 2018-01-04
CureVac AG. (1/4/18). "Press Release: CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-mediated mRNA Therapeutics". Tübingen, Boston, MA & San Diego, CA. 2018-01-04
Miracor Medical S.A.. (1/4/18). "Press Release: Miracor Medical Raises €25m. Funds Will Be Used to Support Clinical and Prepare Commercial Activities – Company Relocates from Austria to Belgium". Awans & Vienna. 2018-01-04
Enterome S.A.. (1/4/18). "Press Release: Enterome Raises €32 Million ($38.5 Million) in a Series D Financing". Paris & Cambridge, MA. 2018-01-04
Rewind Therapeutics. (1/4/18). "Press Release: Rewind Therapeutics Secures 15.2m Euro to Develop Novel Remyelination Therapies". Leuven. 2018-01-04
Themis Bioscience GmbH. (1/4/18). "Press Release: Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline". Vienna. 2018-01-04
Roche. (1/4/18). "Press Release: Roche Launches the cobas Plasma Separation Card to Increase Access to HIV testing for Patients Living in Remote Areas". Basel. 2018-01-04
CRISPR Therapeutics AG. (1/4/18). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. 2018-01-04
Cellestia Biotech AG. (1/4/18). "Press Release: First Patient Dosed in First-in-human Phase l-lla Clinical Study with Cellestia’s Proprietary, Protein-protein Interaction Inhibitor CB-103 Targeting the NOTCH Oncogenic Signalling Pathway in Cancer". Basel 2018-01-04
Oculis S.A.. (1/4/18). "Press Release: Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases". Lausanne. 2018-01-04
Biocrates Life Sciences AG. (1/3/18). "Press Release: Biocrates Life Sciences AG Acquires Metanomics Health GmbH to Create a New Global Leader in Metabolomics and Early Disease Detection". Innsbruck. 2018-01-03
Addex Therapeutics S.A.. (1/3/18). "Press Release: Addex and Indivior Sign Strategic Partnership to Accelerate Development of GABAB PAMs as Addiction Treatments". Geneva. 2018-01-03
Boehringer Ingelheim. (1/3/18). "Press Release: Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€". Ingelheim & Boston, MA. 2018-01-03
CRISPR Therapeutics AG. (1/3/18). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. 2018-01-03
Clariant. (1/2/18). "Press Release: Clariant and Global Bioenergies Unveil Development of New Bio-based Cosmetics Polymer for More Natural Formulations". Muttenz & Evry. 2018-01-02
Bruker Corporation. (12/31/17). "Press Release: Bruker Announces Merger of Japan Subsidiaries". Yokohama. 2017-12-31
Roche. (12/22/17). "Press Release: Roche and Ignyta Reach Definitive Merger Agreement. Roche to Acquire Ignyta for US$ 27.00 per Share". Basel. 2017-12-22
Roche. (12/22/17). "Press Release: Roche Commences Tender Offer for All Shares of Ignyta, Inc. for US$ 27.00 per Share in Cash". Basel. 2017-12-22
Helmholtz-Zentrum München. (12/22/17). "Press Release: Launch of Helmholtz Center Munich’s Stem Cell Center". 2017-12-22
GeNeuro S.A.. (12/21/17). "Press Release: GeNeuro To Receive €12 Million Milestone Payment from Servier for Final Patient Visit in GNbAC1 CHANGE-MS Phase 2b Study". Geneva. 2017-12-21
CRISPR Therapeutics AG. (12/21/17). "Press Release: CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board". Zug & Cambridge, MA. 2017-12-21
Genedata AG. (12/20/17). "Press Release: Genedata Profiler Moves To High-performance Clouds". Basel. 2017-12-20
Merck KGaA. (12/20/17). "Press Release: Merck Signs Commercial Supply Agreement with Bluebird Bio for Viral Vector Manufacturing". Darmstadt. 2017-12-20
Merck KGaA. (12/20/17). "Press Release: Merck Collaborates with iCON to Offer BioReliance End-to-End Turnkey Modular MAb Manufacturing Platform". Burlington, MA. 2017-12-20
Idorsia Ltd.. (12/20/17). "Press Release: Idorsia Forms Research Collaboration with Roche in the Field of Cancer Immunotherapy". Allschwil. 2017-12-20
PerkinElmer, Inc.. (12/19/17). "Press Release: PerkinElmer Completes Acquisition of Euroimmun". Waltham, MA. 2017-12-19
Genedata AG. (12/19/17). "Press Release: Genedata Screener Celebrates 15 Years of Increasing In-Vitro Screening Efficiency at Global Pharmas, Biotechs, and CROs". Basel. 2017-12-19
Merck KGaA. (12/19/17). "Press Release: Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt. 2017-12-19
Confo Therapeutics N.V.. (12/19/17). "Press Release: Confo Therapeutics Enters into Drug Discovery Collaboration with Roche". Ghent. 2017-12-19
Bruker Corporation. (12/19/17). "Press Release: Bruker Celebrated the 100th Customer of Its Newly Introduced Tracer 5i Handheld XRF Elemental Analyzer Optimized for Advanced Applications and Research at Pennsylvania State University". Kennewick, WA. 2017-12-19
Intellia Therapeutics, Inc.. (12/18/17). "Press Release: Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer". Cambridge, MA. 2017-12-18
Boehringer Ingelheim. (12/18/17). "Press Release: Autifony Therapeutics and Boehringer Ingelheim Collaborate on a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage & Ingelheim. 2017-12-18
German Accelerator Life Sciences. (12/18/17). "Press Release: German Accelerator Life Sciences (GALS) Partner Ada Health Expands to the US Upon Closing $47M Funding Round". 2017-12-18
Horizon Discovery Group plc. (12/18/17). "Press Release: Horizon Discovery Enters into Agreement with Roche Diagnostics to Support the Development of Immunohistochemistry Assays for Oncology". Cambridge. 2017-12-18
AB Sciex (d/b/a Sciex). (12/18/17). "Press Release: Sciex and NofaLab Collaboration Delivers Robust and Sensitive Method for Detecting Multiple Pesticides in a Single Run". Warrington, UK. 2017-12-18
Boehringer Ingelheim. (12/15/17). "Press Release: Change in the Board of Managing Directors at Boehringer Ingelheim". Ingelheim. 2017-12-15
Siemens AG. (12/15/17). "Press Release: Siemens Healthineers Announces Acquisition of Fast Track Diagnostics". Erlangen. 2017-12-15
BRAIN AG. (12/15/17). "Press Release: BRAIN Achieves Clear Improvement in Revenues and Earnings in the 2016/17 Financial Year". Zwingenberg. 2017-12-15
Merck KGaA. (12/15/17). "Press Release: Petra Wicklandt Appointed Head of Corporate Affairs at Merck". Darmstadt. 2017-12-15
High-Tech Gründerfonds Management GmbH. (12/14/17). "Press Release: GeneQuine Biotherapeutics’ Gene Therapy Program for Treatment of Knee Osteoarthritis Acquired by Flexion Therapeutics". 2017-12-14
Flexion Therapeutics, Inc.. (12/13/17). "Press Release: Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee". Burlington, MA. 2017-12-13
Bruker Corporation. (12/13/17). "Press Release: Bruker and The Metropolitan Museum of Art Announce Partnership in the Field of Cultural Heritage Science". New York, NY & Billerica, MA. 2017-12-13
Evotec AG. (12/13/17). "Press Release: Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal diseases". Dresden & Hamburg. 2017-12-13
Immunic AG. (12/12/17). "Press Release: Immunic Therapeutics Successfully Completes Two Phase 1 Studies for IMU-838". Planegg-Martinsried. 2017-12-12
NorthSea Therapeutics B.V.. (12/12/17). "Press Release: NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug". Naarden. 2017-12-12
BRAIN AG. (12/12/17). "Press Release: BRAIN AG and Mannheim University Develop 3D Skin Models for Health Care and Cosmetics". Zwingenberg & Mannheim. 2017-12-12
Genedata AG. (12/12/17). "Press Release: Genedata and Titian Collaborate to Deliver Seamless Flow from Sample Inventory to Data Analysis". Basel & London. 2017-12-12
Merck KGaA. (12/12/17). "Press Release: Allan Gabor Takes Over the Leadership of Merck in China". Darmstadt. 2017-12-12
next pagenext page 1 2 3 ... 17 18 19 ... 97 98 99  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 650x65px

» top